{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:23:03Z","timestamp":1792581783707,"version":"4.5.0"},"reference-count":18,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2024,8,12]]},"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                  <jats:title>Background\/aims<\/jats:title>\n                  <jats:p>This study reports on the long-term functional and anatomical outcomes of patients with central retinal vein occlusion (CRVO) treated under the Bern treat-and-extend (T&amp;E) protocol.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Observational study. Treatment-naive patients with CRVO and consecutive macular oedema treated with aflibercept were included. The T&amp;E protocol involved 2\u2009monthly injections followed by an extension based on individual assessments. At each visit, best-corrected visual acuity (BCVA), optical coherence tomography imaging and a 2\u2009mg aflibercept injection were administered. Changes in BCVA, proportion of patients gaining \u226515 letters, central subfield thickness (CST) and treatment intervals were analysed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Out of 173 patients, 64 had a follow-up of at least 2 years. BCVA improved from 46.7\u00b125.3 at baseline to 78.3\u00b10.5 at year 9. The proportion of patients with \u226515 letters gained was 56%, 53%, 56%, 62%, 52%, 52%, 43%, 50% and 33% at years 1\u20139, respectively. CST decreased significantly from 660\u00b1242\u2009\u00b5m at baseline to 359\u00b163\u2009\u00b5m at year 9. Treatment intervals extended from 4 weeks initially to an average of 13.0\u00b14.1 weeks by year 8.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The T&amp;E regimen for CRVO shows sustained visual improvements and reduced CST over time. Patients maintained stable visual gains for many years, demonstrating the effectiveness of this treatment approach. However, no control group was available to compare our T&amp;E regimen with other strategies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2024-001659","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T04:40:24Z","timestamp":1724474424000},"page":"e001659","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Aflibercept for central retinal vein occlusions: long-term outcomes of a \u2018Treat-and-Extend\u2019 regimen"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3670-6983","authenticated-orcid":false,"given":"Damian","family":"Jaggi","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Inselspital University Hospital Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanoosha","family":"Nagamany","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital University Hospital Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital University Hospital Bern, Bern, Switzerland"},{"name":"Bern Photographic Reading Center, Inselspital, University Hospital Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3447-2359","authenticated-orcid":false,"given":"Martin S.","family":"Zinkernagel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital University Hospital Bern, Bern, Switzerland"},{"name":"Bern Photographic Reading Center, Inselspital, University Hospital Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian M.","family":"Heussen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital University Hospital Bern, Bern, Switzerland"},{"name":"Bern Photographic Reading Center, Inselspital, University Hospital Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"2025090109411019000_9.1.e001659.1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1996.01100140443012"},{"key":"2025090109411019000_9.1.e001659.2","first-page":"133","article-title":"The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study","volume":"98","author":"Klein","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2025090109411019000_9.1.e001659.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.04.019"},{"key":"2025090109411019000_9.1.e001659.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.01.022"},{"key":"2025090109411019000_9.1.e001659.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.01.042"},{"key":"2025090109411019000_9.1.e001659.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.02.022"},{"key":"2025090109411019000_9.1.e001659.7","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ajo.2014.07.027","article-title":"Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study","volume":"158","author":"Ogura","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"2025090109411019000_9.1.e001659.8","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000134"},{"key":"2025090109411019000_9.1.e001659.9","doi-asserted-by":"crossref","first-page":"e1199","DOI":"10.1111\/aos.15068","article-title":"Treat-and-extend regimens of anti-vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta-analysis","volume":"100","author":"Nanji","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"2025090109411019000_9.1.e001659.10","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-316514"},{"key":"2025090109411019000_9.1.e001659.11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40123-019-0184-8","article-title":"Real-Life Evidence for Using a Treat-and-Extend Injection Regime for Patients with Central Retinal Vein Occlusion","volume":"8","author":"Eleftheriadou","year":"2019","journal-title":"Ophthalmol Ther"},{"key":"2025090109411019000_9.1.e001659.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2018-000249","article-title":"Five-year outcomes of retinal vein occlusion treated with vascular endothelial growth factor inhibitors","volume":"4","author":"Spooner","year":"2019","journal-title":"BMJ Open Ophthalmol"},{"key":"2025090109411019000_9.1.e001659.13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ajo.2022.04.001","article-title":"Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion","volume":"240","author":"Scott","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"2025090109411019000_9.1.e001659.14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/IAE.0000000000001923","article-title":"EXIT STRATEGY IN A TREAT-AND-EXTEND REGIMEN FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION","volume":"39","author":"Arendt","year":"2019","journal-title":"Retina (Philadelphia, Pa)"},{"key":"2025090109411019000_9.1.e001659.15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2019.03.029","article-title":"Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema","volume":"205","author":"Iftikhar","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"2025090109411019000_9.1.e001659.16","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/IAE.0000000000002171","article-title":"INJECTION FREQUENCY OF AFLIBERCEPT VERSUS RANIBIZUMAB IN A TREAT-AND-EXTEND REGIMEN FOR CENTRAL RETINAL VEIN OCCLUSION: A Randomized Clinical Trial","volume":"39","author":"Casselholm de Salles","year":"2019","journal-title":"Retina (Philadelphia, Pa)"},{"key":"2025090109411019000_9.1.e001659.17","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1111\/aos.15756","article-title":"Treatment patterns and visual acuity change of AMD patients, before, during and after the COVID-19 pandemic lockdowns: A large cohort","volume":"102","author":"Barequet","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"2025090109411019000_9.1.e001659.18","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-023-02261-x","article-title":"Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis","volume":"12","author":"Shahzad","year":"2023","journal-title":"Syst Rev"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2024-001659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:41:21Z","timestamp":1756744881000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2024-001659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,8,24]]},"published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1136\/bmjophth-2024-001659"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2024-001659","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}